These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 27899275)

  • 21. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the adjuvant activity of propranolol, a Beta-adrenergic receptor antagonist, on efficacy of a malaria vaccine model in BALB/c mice.
    Shahabi S; Mohammadzadeh Hajipirloo H; Keramati A; Hazrati Tappeh K; Bozorgomid A
    Iran J Allergy Asthma Immunol; 2014 Oct; 13(5):307-16. PubMed ID: 25150071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of different cytokines on the tumorigenicity and immunogenicity of murine tumors.
    Chen YM; Tsai CM; Perng RP
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Nov; 62(11):807-16. PubMed ID: 10575810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells.
    Gao X; Wang X; Yang Q; Zhao X; Wen W; Li G; Lu J; Qin W; Qi Y; Xie F; Jiang J; Wu C; Zhang X; Chen X; Turnquist H; Zhu Y; Lu B
    J Immunol; 2015 Jan; 194(1):438-45. PubMed ID: 25429071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ascophyllan functions as an adjuvant to promote anti-cancer effect by dendritic cell activation.
    Zhang W; Okimura T; Xu L; Zhang L; Oda T; Kwak M; Yu Q; Jin JO
    Oncotarget; 2016 Apr; 7(15):19284-98. PubMed ID: 27008707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma.
    Tatsumi T; Takehara T; Kanto T; Miyagi T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N
    Cancer Res; 2001 Oct; 61(20):7563-7. PubMed ID: 11606395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening of cytokines to enhance vaccine effects of heat shock protein 70-rich tumor cell lysate.
    Ito A; Fujioka M; Tanaka K; Kobayashi T; Honda H
    J Biosci Bioeng; 2005 Jul; 100(1):36-42. PubMed ID: 16233848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eps8 vaccine exerts prophylactic antitumor effects in a murine model: a novel vaccine for breast carcinoma.
    He YJ; Zhou J; Zhao TF; Hu LS; Gan JY; Deng L; Li Y
    Mol Med Rep; 2013 Aug; 8(2):662-8. PubMed ID: 23754615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cytotoxic activity of spleen lymphocytes in BALB/c mice immunized by HSP110-HER2/neu ICD].
    Han D; Xu H; Yan WQ
    Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):11-4. PubMed ID: 22490848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
    Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
    Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant Effect of Biogenic Selenium Nanoparticles Improves the Immune Responses and Survival of Mice Receiving 4T1 Cell Antigens as Vaccine in Breast Cancer Murine Model.
    Yazdi MH; Varastehmoradi B; Faghfuri E; Mavandadnejad F; Mahdavi M; Shahverdi AR
    J Nanosci Nanotechnol; 2015 Dec; 15(12):10165-72. PubMed ID: 26682463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapeutic effects of B and T lymphocyte attenuator extracellular domain and heat shock protein 70 antigen peptide on cervical cancer in mouse model].
    Han LF; Qiu WM; Hu C; Wang L; Yao HX; Xiong SY; Meng M; Fang Y; Ma D
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):603-8. PubMed ID: 21029617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melittin-MIL-2 fusion protein as a candidate for cancer immunotherapy.
    Liu M; Wang H; Liu L; Wang B; Sun G
    J Transl Med; 2016 Jun; 14(1):155. PubMed ID: 27246873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunopotentiation of novel adjuvant SWZY on the poorly immunogenic murine melanoma vaccine].
    Zhou Y; Qi X; Xiao JX; Lai BC; Si LS; Wang YL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):526-9. PubMed ID: 16806024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Favorable alteration of tumor microenvironment by immunomodulatory cytokines for efficient T-cell therapy in solid tumors.
    Tähtinen S; Kaikkonen S; Merisalo-Soikkeli M; Grönberg-Vähä-Koskela S; Kanerva A; Parviainen S; Vähä-Koskela M; Hemminki A
    PLoS One; 2015; 10(6):e0131242. PubMed ID: 26107883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed tumor onset and reduced tumor growth progression after immunization with a Her-2/neu multi-peptide vaccine and IL-12 in c-neu transgenic mice.
    Wagner S; Jasinska J; Breiteneder H; Kundi M; Pehamberger H; Scheiner O; Zielinski CC; Wiedermann U
    Breast Cancer Res Treat; 2007 Nov; 106(1):29-38. PubMed ID: 17203384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of hepatic cancer in mice by beta-elemene combined DC/Dribble vaccine: an immune mechanism research].
    Ni FF; Liu YJ; Zhou H; Lin L; Liu ZW; Shen H; Wang LX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Feb; 33(2):214-9. PubMed ID: 23646477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential administration of GM-CSF and IL-2 surface-modified MB49 cells vaccines against the metastatic bladder cancer.
    Shi X; Zhang X; Li J; Guo F; Hu Z; Jing Y; Bai L; Chen S; Wan P; Wang F; Gao J; Tan W
    Urol Oncol; 2013 Aug; 31(6):883-93. PubMed ID: 21924648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uric acid enhances the antitumor immunity of dendritic cell-based vaccine.
    Wang Y; Ma X; Su C; Peng B; Du J; Jia H; Luo M; Fang C; Wei Y
    Sci Rep; 2015 Nov; 5():16427. PubMed ID: 26553557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Naloxone/alum mixture a potent adjuvant for HIV-1 vaccine: induction of cellular and poly-isotypic humoral immune responses.
    Velashjerdi Farahani S; Reza Aghasadeghi M; Memarnejadian A; Faezi S; Shahosseini Z; Mahdavi M
    Pathog Glob Health; 2016 Mar; 110(2):39-47. PubMed ID: 26403975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.